Related Experiment Video
Updated: Jan 10, 2026

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
Published on: August 31, 2022
Radiomics of Hepatocellular Carcinoma: Identifying Predictors of Microvascular Invasion Using Multi-Phase CT Analysis
Flavio Spoto1, Nicolo' Cardobi1, Riccardo De Robertis1
1Department of Diagnostics and Public Health Radiology Institute, Policlinico 'G. B. Rossi', Integrated University Hospital of Verona, P.le L.A. Scuro n. 10, 37134 Verona, Italy.
Abstract:
Objective: To explore radiomic texture features from multi-phase contrast-enhanced CT as potential predictors of microvascular invasion (MVI) in hepatocellular carcinoma (HCC). Materials and Methods: This exploratory single-center study retrospectively analyzed 49 patients (54 HCC lesions) who underwent liver resection between 2018-2022. Radiomic analysis extracted 642 features across arterial, venous, and delayed phases using original and 5 mm-expanded tumor margins. Results: The 20-50 mm lesion subgroup (n = 37) provided the most reliable results, with arterial phase texture homogeneity features achieving AUC 0.772. Features from lesions <20 mm (n = 14, 4 MVI+) showed clear evidence of overfitting and were excluded from primary analyses. Delayed phase features showed preliminary associations (AUC 0.8) in a small LR-3/4 subset (n = 20). Limitations: This hypothesis-generating study has significant limitations including small sample size, single-center design, and lack of correction for multiple comparisons. Conclusions: Multi-phase CT radiomic analysis shows potential for MVI prediction in intermediate-sized HCC lesions, though external validation in larger cohorts is essential before clinical application.
More Related Videos
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023